Muhammad Haroon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Muhammad Haroon has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Ahmad Raza
Department of Medicine, Medical Officer, Medicine Unit 1, Benazir Bhutto Hospital, Rawalpindi, Pakistan
1 shared publication Azeen Razzaq
Department of Medicine, Medical Officer, Medicine Unit 1, Benazir Bhutto Hospital, Rawalpindi, Pakistan
1 shared publication- Beenish Mbbs Sabir
Department of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan
1 shared publication - Fatima Hajj
Faculty of Medicine, Lebanese University, Beirut, Lebanon
1 shared publication - Muhammad Usman Iqbal
Department of Medicine, King Edward Medical University, Lahore, Pakistan
1 shared publication - Shafaq Saleem
Benazir Bhutto Hospital, Rawalpindi, Pakistan
1 shared publication
Latest Publications
- Open Access
- 15 July 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (8) , 5488-5493
Concurrent postpartum cerebral venous thrombosis and acute toxoplasmosis–debut of a unique clinical convergence: a case report
Introduction and importance: Cerebral venous thrombosis (CVT) is a rare but serious condition, with pregnancy and puerperium representing major risk factors. Toxoplasma gondii typically causes asymptomatic infection in immunocompetent individuals. No case of concurrent postpartum CVT and acute toxoplasmosis has previously been reported. Case presentation: A 27-year-old woman presented 14 days postpartum with headache, fever, altered sensorium, and left-sided weakness. Neurological examination revealed a Glasgow Coma Scale score of 8/15 with focal deficits. Serology demonstrated positive Toxoplasma gondii IgM antibodies, indicating a recent infection. MRI/MRV confirmed multiple venous infarcts with hemorrhagic transformation, consistent with CVT. Protein C and S levels were reduced; however, these were interpreted cautiously, as acute thrombosis, systemic inflammation, and puerperium can transiently lower natural anticoagulant levels. Repeat testing post-recovery was planned. The patient was managed with anticoagulation, corticosteroids, and supportive care, followed by oral rivaroxaban and physiotherapy, achieving significant neurological recovery over 2 months. Clinical discussion: The concurrence of postpartum CVT and positive Toxoplasma gondii serology is unprecedented. Pregnancy-related hypercoagulability, compounded by infection-induced endothelial dysfunction, likely contributed to thrombosis. Reduced Protein C and S levels, measured during acute thrombosis or puerperium, may not reflect inherited deficiency; repeat testing after anticoagulation completion is necessary before diagnosing congenital deficiency. Anticoagulation, per international guidelines, remained the cornerstone of management and proved effective despite hemorrhagic infarcts. Conclusion: This first documented case of postpartum CVT with concurrent Toxoplasma gondii serology suggestive of recent infection underscores the importance of prompt recognition and timely anticoagulation.
- 15 July 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (8) , 5488-5493
Open AccessConcurrent postpartum cerebral venous thrombosis and acute toxoplasmosis–debut of a unique clinical convergence: a case report
Introduction and importance: Cerebral venous thrombosis (CVT) is a rare but serious condition, with pregnancy and puerperium representing major risk factors. Toxoplasma gondii typically causes asymptomatic infection in immunocompetent individuals. No case of concurrent postpartum CVT and acute toxoplasmosis has previously been reported. Case presentation: A 27-year-old woman presented 14 days postpartum with headache, fever, altered sensorium, and left-sided weakness. Neurological examination revealed a Glasgow Coma Scale score of 8/15 with focal deficits. Serology demonstrated positive Toxoplasma gondii IgM antibodies, indicating a recent infection. MRI/MRV confirmed multiple venous infarcts with hemorrhagic transformation, consistent with CVT. Protein C and S levels were reduced; however, these were interpreted cautiously, as acute thrombosis, systemic inflammation, and puerperium can transiently lower natural anticoagulant levels. Repeat testing post-recovery was planned. The patient was managed with anticoagulation, corticosteroids, and supportive care, followed by oral rivaroxaban and physiotherapy, achieving significant neurological recovery over 2 months. Clinical discussion: The concurrence of postpartum CVT and positive Toxoplasma gondii serology is unprecedented. Pregnancy-related hypercoagulability, compounded by infection-induced endothelial dysfunction, likely contributed to thrombosis. Reduced Protein C and S levels, measured during acute thrombosis or puerperium, may not reflect inherited deficiency; repeat testing after anticoagulation completion is necessary before diagnosing congenital deficiency. Anticoagulation, per international guidelines, remained the cornerstone of management and proved effective despite hemorrhagic infarcts. Conclusion: This first documented case of postpartum CVT with concurrent Toxoplasma gondii serology suggestive of recent infection underscores the importance of prompt recognition and timely anticoagulation.